193 Cisplatin-based chemotherapy remains the primary treatment for advanced gastric cancer, however, chemotherapy resistance remains a significant challenge to clinical efficacy
First, we selected candidate residues for the potential glutathione activator site and the glutathione-scaffold site
Common Side Effects and Practical Safety Considerations No clinician should promise zero side effects. A more useful promise is predictable risk management. Here are the most common issues seen in peptide protocols, including stacks: 1) Injection site reactions Mild redness, itching, swelling, or tenderness can occur at the injection site
These approaches address the actual mechanism causing nausea rather than adding unrelated compounds
Warchol, Washington University School of Medicine, USA
Thats not an oversight